Torrent Pharmaceuticals Ltd (NSE:TORNTPHARM)
₹ 2612.55 -80.35 (-2.98%) Market Cap: 884.21 Bil Enterprise Value: 912.62 Bil PE Ratio: 59.16 PB Ratio: 13.18 GF Score: 96/100

Q2 2024 Torrent Pharmaceuticals Ltd Earnings Call Transcript

Oct 23, 2023 / 12:30PM GMT
Release Date Price: ₹1877.3 (-0.76%)
Operator

Ladies and gentlemen, good day, and welcome to the Q2 FY '24 Earnings Conference Call of Torrent Pharma.

(Operator Instructions)

Please note that this conference is being recorded.

I now hand the conference over to Mr. Sudhir Menon, Chief Financial Officer and Executive Director, Finance. Thank you, and over to you, sir.

Sudhir Menon
Torrent Pharmaceuticals Limited - Executive Director of Finance & CFO

Thank you. Good evening to all of you, and welcome to the Second Quarter Earnings Call for FY '24. I'm pleased to share the details of our strong performance this quarter across all our focus markets. The branded business contributed to 73% of the overall revenue base this quarter and have grown by 18%. Germany with incremental tender wins over the last 3 quarters has helped in registering a constant currency, high single-digit growth. U.S., we continue to take measures to enhance the cost efficiency in the base business, while we await new product approvals to start flowing in the future quarters, and this should start adding

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot